Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population

Circulation

Volumn 104, Issue 5, 2001, Pages 539-543

  Taniuchi, Megumi ^a,b   Kurz, Howard I ^a   Lasala, John M ^a  

^a BARNES JEWISH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angioplasty; Pharmacology; Platelets; Stents; Thrombosis

Indexed keywords

ABCIXIMAB; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; PLACEBO; THIENO[3,2 C]PYRIDINE DERIVATIVE; TICLOPIDINE; TIROFIBAN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HIGH RISK PATIENT; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; POPULATION RESEARCH; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; WOUND CLOSURE;

EID: 0035979401     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3001.093435     Document Type: Article

References (17)

1. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
2. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
3. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
4. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting
5. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS)
6. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
7. Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention
8. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates
9. Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis
10. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation
11. Clopidogrel versus ticlopidine after intracoronary stent placement
12. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents
13. Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement
14. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The clopidogrel aspirin stent international cooperative study (CLASSICS)
15. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
16. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade
17. Incidence of thrombocytopenia following coronary stent placement using abciximab plus clopidogrel or ticlopidine